# Optimal lab ranges: how clinics set and govern them

Source: https://www.longevityehr.com/biomarkers/optimal-ranges

The range printed on a lab report describes a population. An optimal range describes a clinic's target. Both are useful, they answer different questions, and the second one needs an owner, a source and a review date.

Last updated: 2026-10-21

## Key takeaways

- A lab reference interval describes where most healthy people in a reference population fall. It is not a statement about future risk.
- Guideline decision limits, such as the ApoB and Lp(a) thresholds in lipid guidelines, are a different thing again: points where risk or treatment changes.
- Optimal lab ranges are targets a clinic chooses. They are legitimate when each one has a written source, an owner and a review date.
- The main risks are over-flagging, undocumented numbers, unit and assay mismatches, and silently regrading past results.
- In a clinic, range setting works best as an account-level decision approved by the clinical lead, not an edit any user can make.

## Facts

- Reference interval: Usually the central 95% of a healthy reference population (2.5th to 97.5th percentile)
- Minimum sample: At least 120 reference individuals, per the CLSI and IFCC guideline
- Who verifies it: The laboratory, under CLIA (42 CFR 493.1253)
- Optimal range: A target the clinic defines, documents and reviews

## Reference range vs optimal range

Three kinds of numbers end up next to a lab result, and most confusion about optimal lab ranges comes from treating them as one.

|   | Reference interval | Clinical decision limit | Clinic optimal range |
| --- | --- | --- | --- |
| What it describes | Where most healthy people in a reference population fall | A value above or below which a specific medical decision is recommended | The target a clinic reads results against |
| Who sets it | The laboratory | A guideline or consensus body | The clinic, usually its medical director |
| How it is built | Percentiles of a reference population | Outcome and trial evidence, expert consensus | Clinical judgment, ideally anchored to published evidence |
| Example | The interval printed on the report | The 2018 AHA/ACC risk-enhancing factor for Lp(a): 50 mg/dL or higher, or 125 nmol/L or higher | A clinic's own optimal band for a marker it tracks |

"Functional medicine lab ranges" and "functional lab ranges" are names for the third column. They are not a separate standard. Each practice, or each vendor that sells a fixed set, decides its own numbers.

## How laboratory reference intervals are built

A reference interval is a statistical description. As a 2016 review in Biochemia Medica summarizes the CLSI and IFCC guidance, a laboratory measures a group of healthy reference individuals and reports the central 95% of their results. The lower limit is the 2.5th percentile and the upper limit the 97.5th.

- **Sample size.** At least 120 reference individuals are needed to calculate confidence intervals for the limits.
- **Transference.** A laboratory can adopt an interval established elsewhere after checking a small number of its own reference individuals (the guideline suggests 20).
- **Partitioning.** Stratification by age and sex is described as the minimum prerequisite for a useful interval.
- **Population differences.** Intervals can differ materially between populations and methods, which is why one laboratory's numbers do not always transfer to another.

US law puts this work on the laboratory. Under CLIA, a laboratory must verify that a manufacturer's reference intervals are appropriate for its patient population, and must establish reference intervals itself for tests it has modified or developed (42 CFR 493.1253).

### What a reference interval does not tell you

By construction, about 5% of results from healthy people fall outside the interval. Run many tests and the chance of at least one flag rises quickly: if 20 tests were independent, the probability that at least one healthy result falls outside its interval would be about 64% (1 minus 0.95 to the 20th power). And because the interval describes a population as it is today, it says nothing direct about which values carry lower long-term risk.

## Why clinics define their own targets

Longevity, functional and preventive practices tend to ask a different question from the lab. The lab asks whether a value is unusual for its reference population. The clinic asks whether a value matches the target it works toward with this patient, and whether it is moving in the right direction.

Sometimes the evidence itself points to a tighter number than the population interval. The 2024 National Lipid Association consensus on ApoB places about 130 mg/dL near the 90th percentile of untreated US adults, yet proposes 60, 70 or 90 mg/dL as thresholds to consider when intensifying therapy, depending on risk. A population interval and a risk threshold can sit far apart. Our [ApoB](https://www.longevityehr.com/biomarkers/apob) page covers that example in detail.

Other targets rest more on clinical judgment than on a guideline. That is not a problem in itself. It becomes one when nobody can say where a number came from.

## The risks of optimal ranges

- **Over-flagging.** A tighter band classifies more results as out of range. That can mean more retesting, more follow-up and more worried patients.
- **Numbers without a source.** A range copied from a course, a vendor or a colleague, with no reference attached, cannot be defended or reviewed.
- **Units and assays.** A band set in one unit or on one assay can be wrong on another. Lp(a) in mg/dL and nmol/L have no fixed conversion, and insulin assays disagree enough to move HOMA-IR. See [Lp(a)](https://www.longevityehr.com/biomarkers/lipoprotein-a) and [HOMA-IR](https://www.longevityehr.com/biomarkers/homa-ir).
- **Missing partitions.** Many analytes have sex-specific intervals, and some vary with age. One band for everyone can misclassify part of the panel.
- **Two ranges, one patient.** When the lab's interval and the clinic's band disagree, the patient needs to know which one the provider is using and why.
- **Silent regrading.** If a range edit changes how old results are classified, a patient's history quietly changes meaning.

## How to document and govern optimal lab ranges

The closest governance model in ambulatory practice is the standing order or clinical protocol. A 2018 Family Practice Management article on standing orders says the medical director is responsible for approving them, that all clinicians should agree with them, that each should carry the date it was written or last reviewed, and that they should be reassessed at least every two years. A clinic's range set is the same kind of artifact.

1. List the biomarkers the clinic tracks, and turn off the ones it does not.
2. For each band, record the source: a guideline, a consensus statement, a named study, or a written clinical rationale.
3. Record the unit and any assay assumption. If the number only holds for one unit or method, say so.
4. Decide the partitions: sex at minimum where intervals differ, and note where age matters.
5. Have the medical director approve the set, with the other clinicians in agreement.
6. Date it, and set a review cadence. Review sooner when a guideline changes.
7. Decide how patients see it: which range appears in the portal, and what the provider says when it differs from the lab's.
8. Make sure an edit never rewrites the meaning of past results.

### Who should set ranges in a clinic

Range setting is a clinic-wide clinical decision, not a per-patient one. It belongs in account-level settings, held by whoever carries clinical authority for the practice. A range any user can change becomes a range nobody owns.

## How LongevityEHR handles optimal ranges

LongevityEHR is an EHR for cash-pay longevity, functional and concierge clinics. It was designed around the governance above. It does not decide what is optimal for your patients, and it does not interpret results.

- **Ranges per clinic and per sex.** Each biomarker can carry optimal, borderline and critical bands, split into Female, Male and Unknown when you need it. See [biomarker tracking](https://www.longevityehr.com/biomarker-tracking).
- **One owner.** Range configuration belongs to the clinic owner. Other providers see the ranges and work with them, but cannot change them.
- **Deterministic grading.** A released value is classified by comparing it with your band. No AI interprets it, and the provider writes every word of interpretation.
- **History that keeps its meaning.** Each released value stores a snapshot of the range that applied that day. Editing a range on a biomarker with released results asks for confirmation and applies only to future releases.
- **Clean inputs.** [AI lab extraction](https://www.longevityehr.com/ai-lab-extraction) reads values from lab PDFs and images, flags low-confidence values, unit mismatches and duplicates, and never converts units silently. A provider reviews and releases every result.

Clinics in [functional medicine](https://www.longevityehr.com/functional-medicine-ehr) often arrive with a spreadsheet of targets built over years. That spreadsheet, with its sources attached, is the right starting point.

## Frequently asked questions

### What is the difference between a reference range and an optimal range?

A reference range is set by the laboratory and usually covers the central 95% of a healthy reference population. An optimal range is a target a clinic chooses for its own patients, and it should be documented with its source.

### What are functional medicine lab ranges?

They are optimal ranges used by functional and integrative practices, usually tighter than the lab's reference interval. There is no single published standard, so each practice or vendor defines its own.

### Who should set optimal lab ranges in a clinic?

Treat them like a clinical protocol: approved by the medical director, agreed by the clinicians who use them, dated and reviewed on a schedule.

### Are optimal lab ranges evidence based?

It depends on the marker and the source. Some align with guideline decision thresholds, others rest on clinical judgment, which is why each band should carry a written source.

### Does LongevityEHR let clinics set their own ranges?

Yes. The clinic owner sets optimal, borderline and critical bands per biomarker and per sex, and every released result keeps the range that applied on the day it was recorded.

## Sources

- [Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochem Med (Zagreb). 2016;26(1):5-11](https://pmc.ncbi.nlm.nih.gov/articles/PMC4783089/)
- [42 CFR 493.1253, Standard: Establishment and verification of performance specifications](https://www.law.cornell.edu/cfr/text/42/493.1253)
- [Leubner J, Wild S. Developing standing orders to help your team work to the highest level. Fam Pract Manag. 2018;25(3):13-16](https://www.aafp.org/pubs/fpm/issues/2018/0500/p13.html)
- [Soffer DE, Marston NA, Maki KC, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association. J Clin Lipidol. 2024;18(5):e647-e663](https://pmc.ncbi.nlm.nih.gov/articles/PMC11734832/)
- [Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143](https://pmc.ncbi.nlm.nih.gov/articles/PMC7403606/)
- [Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946](https://pmc.ncbi.nlm.nih.gov/articles/PMC9639807/)